Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA 2023-11-11 20:36
SeekIn Presents Retrospective and Prospective Validation Studies of SeekInCare Multi-omics Multi-cancer Early Detection test at the 20th ICGC Workshop and 7th ARGO Meeting in New York 2023-11-10 21:00
Lecheng, MSD vow to deepen medical cooperation 2023-11-10 18:03
FEBICO actively seeking business partners in United States, introduces "High- Spermidine" chlorella health supplements to satisfy U.S. market 2023-11-10 17:08
TCT 2023: The Efficacy and Safety of the SMART Trial Presented by World Renowned Expert 2023-11-10 16:46
GC Genome Enters License Agreement with MP Group 2023-11-10 13:00
MVR-T3011 IV, Global First Intravenous Oncolytic Product, Successfully Concludes Phase I Clinical Study in the U.S. with Outstanding Safety Results 2023-11-10 08:00
PharmAbcine Receives Safety Review Committee Approval to Advance to Dose Level 2 of Clinical Trial of PMC-403 with Neovascular Age-related Macular Degeneration following Dose Level 1 Safety Data 2023-11-09 21:00
Eccogene Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases 2023-11-09 15:05
WuXi AppTec Named 2023 Global Contract Research, Development and Manufacturing Organization Company of the Year by Frost & Sullivan 2023-11-09 08:00
Holmusk Appoints Eze Abosi as Chief Growth Officer 2023-11-09 08:00
Porton Advanced Announces a Strategic Partnership with BioMap, with AI Models Facilitating AAV Gene Therapy Development 2023-11-08 22:31
WuXi Biologics Receives AAA MSCI ESG Rating 2023-11-08 08:30
Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial 2023-11-07 21:58
Kexing Biopharm Attended CPHI Worldwide 2023 2023-11-07 20:09
Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis Demonstrating Strong Overall Survival Benefit as First-line Treatment in All-comer Patients with Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) 2023-11-07 20:00
First Mover of Global Trade Index Based On Biome Molecule, Kwanyoung Park of AndKwan Natural Science 2023-11-07 15:47
BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate 2023-11-07 14:14
87.5% ORR | Abbisko presented two clinical updates of Pimicotinib at the 2023 CTOS Annual Meeting 2023-11-07 12:31
AIRS Medical inks partnership agreement with FONAR Corporation, leveraging the experience of the pioneering company in MRI... Success cases to be presented at RSNA 2023 2023-11-07 00:00
1 52 53 54 55 56 431